Here are five key points:
• The shares were sold at an average price of $76.24, for a total of $1.52 million.
• Now, the CEO directly owns 554,396 shares in the company, valued at approximately $42.26 million.
• Medtronic has a 52-week low of $55.85 and a 52-week high of $79.45.
• The company has a market cap of $75.48 billion.
• Medtronic currently has an average rating of “buy” and an average price target of $80.63.
More articles on devices:
DOJ extends Biomet’s deferred prosecution agreement
Oppenheimer updates Globus Medical price target — 5 key notes
Are Medtronic shares undervalued at $77 per share? 7 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
